Sorted By:

Relevance


Biopharmaceutical Leaders: Japanese Patients, Health Care System and Economy Benefit from Access to Innovative Medicines

PhRMA  |  Press Release

We collectively share the responsibility not to give into short-term thinking at the expense of long-term objectives like finding a cure for Alzheimer’s disease.”
https://www.phrma.org

Medicines in Development for Cancer 2015 Report

PhRMA  |  Report

In fact, biopharmaceutical companies are developing 836 medicines and vaccines for cancer, all of which are in clinical trials or awaiting review by the U.S.
https://www.phrma.org/report/medicines-in-development-for-cancer-2015-report

PhRMA Statement Regarding White House Jobs Summit

PhRMA  |  Press Release

In fact, chronic diseases account for 75 cents* out of every health care dollar spent in the U.S.
https://www.phrma.org/press-release/phrma-statement-regarding-white-house-jobs-summit

Research Doesn't End on a Medicine's Approval

PhRMA  |  Video

In fact, that’s when post-approval research and monitoring begin and they help all health care stakeholders, including physicians and patients, to better understand the full value of the medicine.
https://www.phrma.org/video/research-doesn-t-end-on-a-medicine-s-approval

How Medicines Can Curb Health Care Costs

PhRMA  |  Video

Just one extra dollar spent on medicines for adherent patients with congestive heart failure, high blood pressure, diabetes and high cholesterol can generate $3 to $10 in savings on emergency room visits and inpatient hospitalizations.
https://www.phrma.org/video/how-medicines-can-curb-health-care-costs

The Five Essential Truths about Prescription Drug Spending

PhRMA  |  Blog Post

And every additional dollar spent on medicines for adherent patients with congestive heart failure, high blood pressure, diabetes and high cholesterol generated $3 to $10 dollars in savings on emergency room visits and inpatient hospitalizations.
http://catalyst.phrma.org/the-five-essential-truths-about-prescription-drug-spending

Celebrating tremendous advances in HIV/AIDS on National Youth HIV/AIDS Awareness Day

PhRMA  |  Blog Post

In fact, for those diagnosed with HIV at the age of 20, they can expect to live to the age of 70, which is the average life expectancy for the U.S. population as a whole.
http://catalyst.phrma.org/celebrating-tremendous-advances-in-hiv/aids-on-national-youth-hiv/aids-awareness-day

Ask About Adherence: Q&A on appointment-based medication synchronization

PhRMA  |  Blog Post

The cost-benefit of ABMS compared with standard pharmacy dispensing showed medical savings ranging from $1.25 to almost $37 per additional dollar spent depending on the medication class.
http://catalyst.phrma.org/ask-about-adherence-qa-on-appointment-based-medication-synchronization

Medicare Monday: There’s an agency called MedPAC?

PhRMA  |  Blog Post

You may recall the April 2016 recommendations they voted on and sent to Congress regarding harmful changes to Medicare Part D, with which a number of stakeholders raised concerns.
http://catalyst.phrma.org/medicare-monday-theres-an-agency-called-medpac

Senior Director – State Policy (New England Region)

PhRMA  |  PhRMA Career

Professional Experience / Requirements Bachelor’s degree in Public Policy, Health Policy, Political Science, Public Affairs, or another field;  5+ years of progressive experience in state government affairs and/or within state government, legislature, regulatory, or executive branch; Previous experience analyzing policy and developing policy-related action plans; Previous experience working with state health care issues affecting the biopharmaceutical industry; Working knowledge of state health care issues affecting the biopharmaceutical industry; Must be willing to travel (up to 50% of the time during certain times of the year) and be responsive and available after hours and on weekends as needed; must have a valid driver’s license; Be an adaptable, creative problem solver, who is comfortable working in a high-pressure environment;  Excellent interpersonal skills that foster the ability to manage multiple projects simultaneously and meet short non-negotiable timelines.
https://www.phrma.org/careers/senior-director-state-policy-new-england-region

PhRMA Statement on MedPAC Vote

PhRMA  |  Press Release

These recommendations ignore the fact that medicines remain a small and stable share of overall spending while providing significant value to patients.”
https://www.phrma.org/press-release/phrma-statement-on-medpac-vote

Physicians Deserve Timely Authoritative Risk Information For Medicines

PhRMA  |  Blog Post

Our health care system is best served by an open dialogue among all parties to ensure physicians have the most accurate and complete information to meet their patients’ needs.
http://catalyst.phrma.org/physicians-deserve-timely-authoritative-risk-information-for-medicines

PhRMA Statement Supporting U.S. Economic Recovery Advisers

PhRMA  |  Press Release

We look forward to working in partnership to seek a coordinated commitment from a broad range of stakeholders – from private industry to labor to the government – to expand the U.S. manufacturing base and to increase exports.”
https://www.phrma.org/press-release/phrma-statement-supporting-u-s-economic-recovery-advisers

Guest Post: The Clinical trial experience from a patient & researcher perspective

PhRMA  |  Blog Post

I have seen the impact of a clinical trial on countless patients I have worked with in my career; I am excited to be able to speak to the other side of the coin as a patient who can one day be a clinical trial participant, too.
http://catalyst.phrma.org/guest-post-the-clinical-trial-experience-from-a-patient-researcher-perspective

Welcome to the Catalyst

PhRMA  |  Blog Post

We will seek your ideas and recommendations along the way.
http://catalyst.phrma.org/welcome-to-the-catalyst

Medicare Monday: Protecting Beneficiaries Who Receive Extra Help

PhRMA  |  Blog Post

Like other proposals we’ve discussed, this one is short-sighted and could hurt rather than help beneficiaries while altering the successful Medicare Part D program.
http://catalyst.phrma.org/medicare-monday-protecting-beneficiaries-who-receive-extra-help

Why the World Looks to the U.S. for the Most Elusive Cures

PhRMA  |  Blog Post

  In fact, the biopharmaceutical sector spends more on R&D than the entire National Institutes of Health operating budget, with PhRMA member companies investing more than $50 billion in 2013 and over half a trillion dollars since 2000.
http://catalyst.phrma.org/why-the-world-looks-to-the-u.s.-for-the-most-elusive-cures

340B Spotlight: Health Care Costs Rising from Increase in 340B Hospital Acquisitions of Physician Practices

PhRMA  |  Blog Post

In fact, the study found the average reimbursement for Part B oncology drugs was 52 percent higher in 340B hospitals than in community cancer clinics, when compared on a per Medicare beneficiary basis.
http://catalyst.phrma.org/340b-spotlight-health-care-costs-rising-from-increase-in-340b-hospital-acquisitions-of-physician-practices

Director – Public Affairs

PhRMA  |  PhRMA Career

Professional Experience / Requirements Bachelor’s degree; Health care issue experience and expertise; 5+ years of diverse communications experience including significant media relations engagement and daily pitching and responding to media; third-party stakeholder outreach and engagement; proven management of complex issues, projects, tasks, requests, and timelines; and time spent within corporate, government, public relations agency, trade association, and/or advocacy organization(s) or political campaigns; A results-oriented team player; Ability to inspire confidence within the organization and with external constituencies; Ability to balance the needs of various internal and external parties with flexibility and a steady temperament; Must be willing to travel and be responsive/available after hours and on weekends.
https://www.phrma.org/careers/director-public-affairs

Guest Post: Film chronicles clinical trials "paying it forward"

PhRMA  |  Blog Post

In an effort to raise awareness about clinical trial under-enrollment and the value of participation, the Alliance for Aging Research in partnership with PhRMA, recently released a short video on clinical trials—“.youtube.com/watch?
http://catalyst.phrma.org/guest-post-film-chronicles-clinical-trials-paying-it-forward

Breaking a Link in the Value Chain

PhRMA  |  Blog Post

And, in fact, reducing data protection for biologics to seven years would set us behind the current policies in Europe, thereby heightening the competition for our biopharmaceutical sector from abroad.
http://catalyst.phrma.org/breaking-a-link-in-the-value-chain

Some Health Insurance Exchange Plans Put All Treatments for Certain Diseases on Top Cost-Sharing Tier

PhRMA  |  Blog Post

Following reports that patients with health insurance exchange coverage face high deductibles and high-out-of pocket costs for prescription medicines and that even when
http://catalyst.phrma.org/some-health-insurance-exchange-plans-put-all-treatments-for-certain-diseases-on-top-cost-sharing-tie

PhRMA urges CMS to share the savings with seniors

PhRMA  |  Blog Post

In fact, from 2010 to 2015, these rebates increased nearly 24 percent per year, about twice as fast as total Part D drug costs, with manufacturer rebates accounting for the bulk of that growth.
http://catalyst.phrma.org/phrma-urges-cms-to-share-the-savings-with-seniors

India—Seizing the Opportunity

PhRMA  |  Blog Post

I can see the commitment to reach this goal by everyone with whom I talk.
http://catalyst.phrma.org/india-seizing-the-opportunity

Who is Making Decisions About Your Health Care?

PhRMA  |  Blog Post

Step therapy or fail first can be especially challenging for patients with rheumatoid arthritis or other chronic conditions who are stable on a treatment regimen and may see their health worsen if they switch medicines.
http://catalyst.phrma.org/who-is-making-decisions-about-your-health-care

You have reviewed the first 400 results out of 1200. Each page contains 25 results. You're on page 16.

prev 13 14 15 16 17 18 next